Avio Medtech Consulting’s Post

We have selected 14 innovative medtech teams to participate in the Fall 2024 Aspire Medtech investor engagement program! We are impressed and inspired by these teams and their inventions, and thrilled to support them as they prepare for the next step in their entrepreneurial journeys. These medtech companies are developing inventions that include an attachment that converts a traditional wheelchair into a motorized one in just 30 seconds🦽; a low-cost atomizer device that delivers intranasal drugs faster during emergency situations 🚨; and low-cost wound dressings using smart biomaterials, empowering patients to heal and monitor their own wound infections 🩹; among others. For many promising technologies, funding becomes the barrier to scale. These companies will work closely with dedicated investor-mentors to dig deep into how to productively engage with investors. Learn more about their high-impact solutions and follow their progress: https://bit.ly/3N6u9eS

🔍 Medtech’s Capital Surge: Fueling Innovation in Healthcare The medtech sector is experiencing a significant influx of capital, driving innovation and shaping the future of healthcare. As highlighted in this insightful article from MedCity News, the investment boom in medtech is setting the stage for groundbreaking advancements and transforming patient care. 💰 Record-Breaking Investments: The medtech industry is seeing unprecedented levels of capital investment, with both venture capitalists and private equity firms pouring resources into innovative healthcare technologies. 🚀 Innovation Acceleration: This surge in funding is accelerating the development of cutting-edge medical devices, diagnostics, and digital health solutions that promise to revolutionize patient care and outcomes. 🌍 Global Impact: The capital infusion is not limited to the U.S.; international markets are also benefiting, leading to a more connected and advanced global healthcare landscape. 🔄 Shifting Dynamics: As medtech companies secure more funding, the industry is witnessing a shift towards more agile, tech-driven healthcare solutions that can rapidly adapt to changing needs and challenges. 🏥 Focus on Patient-Centric Solutions: The increased investment is enabling medtech companies to focus on creating patient-centric solutions, from wearable health monitors to AI-driven diagnostics, that improve the quality and accessibility of care. The capital surge in medtech is a game-changer for the healthcare industry, fostering an environment where innovation can thrive. With increased funding, medtech companies are well-positioned to deliver transformative solutions that will shape the future of healthcare. This is an exciting time for healthcare professionals, investors, and innovators alike. 👉 Read more here: #Medtech #HealthcareInnovation #DigitalHealth #VentureCapital #PatientCare #HealthTech #Investment #MedtechFunding #FutureOfHealthcare #TechInHealthcare

OptraSCAN just landed $30 million in Series B, and if you think this is just another funding round, think again. Abhi Gholap and his team are taking digital pathology global, and they’re doing it with a vision that’s way bigger than just tech for tech’s sake. Led by Molbio Diagnostics, this round is geared to bring OptraSCAN’s cloud-enabled whole-slide scanning systems and AI-driven analysis to every corner of the healthcare world—making advanced diagnostics as easy to access as a streaming subscription. So here’s the setup: they’re not just selling the latest in slide scanning and AI; they’re putting diagnostics power into places where it’s never been before. With a flexible, pay-per-use model, OptraSCAN’s bringing down the barriers that keep quality healthcare from reaching underserved regions. That’s six patents and counting, all aimed at making it possible for both big-name labs and small clinics to get high-speed, high-accuracy diagnostics at a fraction of the cost and time. Molbio Diagnostics Sriram Natarajan knows what he’s backing: a company with the guts to reshape healthcare access. Molbio’s no stranger to getting life-saving tech into the right hands, and they see OptraSCAN as the future of diagnostics on a global scale. With digital pathology projected to skyrocket to an $8.3 billion market by 2026, OptraSCAN is primed to lead. #HealthCare #HealthTech #Diagnostics #Technology #Innovation #TechEcosystem #StartupEcosystem #VentureCapital #StartupFunding #startups

Hey everyone, have you heard the news? The MedTech Innovator Accelerator just announced its 2024 cohort, and it's a game-changer! With 65 startups at the forefront of medical innovation, we're looking at some seriously exciting developments in the world of healthcare. This year's cohort is incredibly diverse, covering everything from diagnostics and digital health to medical devices. These startups are tackling some of the most pressing healthcare challenges today, and I can't wait to see the impact they'll make. The selection process was no joke - only the most promising and impactful startups made the cut. Now, they'll have access to resources, mentorship, and industry connections that can supercharge their growth and bring their innovations to market more quickly. It's beyond thrilling to see so many creative solutions emerging to improve patient care and outcomes. The MedTech Innovator Accelerator continues to be a critical platform for fostering innovation in the healthcare industry, and I couldn't be more excited about what's to come. I'm genuinely looking forward to seeing how these startups will shape the future of medtech and contribute to better health solutions globally. The future of medical technology is looking brighter than ever, and I'm here for it! https://lnkd.in/guzPcjbg

I'm super excited to be speaking about the financial health in MedTech at this conference by Project Medtech! The industry is changing rapidly and it's reflecting in the data that we track. I'm looking forward to speak about where the industry is headed, where we should be hedging our bets, and some pitfalls to look out for in MedTech. Stay tuned for our Q2 financial report coming later today! #medtech #conference #businessdevelopment #IVD #SaMD

PitchBook's Q3 MedTech report is officially live! PitchBook's analysts provide overviews on emerging opportunities in wound care and smart implants as well as specific company coverage on some of the major players in these spaces! Key Takeaways: • The $3.2 billion of VC funding in Q3 was in line with previous quarters - this quarter also saw a new leader for the largest deal in Medtech this year with Element Biosciences’ $277 million VC round surpassing Freenome’s February $254 million Series F. • Results from the US Election is not expected to have a major impact on the Medtech sector, though on the margin there is likely to be less M&A antitrust scrutiny from the new administration. Two areas of potential change that we're watching: evolving regulation for lab-developed tests (LDTs), and CMS’ coverage decision-making for FDA-designated Breakthrough Devices. • Though VC deal activity has remained in a holding pattern, exits have been picking up and Tempus' successful IPO & solid post-listing share price performance bodes well for the Medtech exit pipeline. In Q3 alone, several startups including Endotronix, Paragonix, Innovalve, and Endomag were all acquired at values exceeding $100 million. • Q3 was an eventful quarter in surgical robotics with new FDA clearances for CMR Surgical (Versius) and Moon Surgical (Maestro), and strong results for publicly traded category leader Intuitive Surgical. And YTD, there has been over $360 million of VC funding in surgical robotics as the sector remains a leading investment category.

“Accept the time it takes. You can move fast on technology development and fail fast. But probably slow down over the clinical and regulatory process, and then be prepared to accelerate really strongly on the back end of that.” Steffen Hovard, CEO of Neuspera Medical Inc., has spent over 30 years in the medical device field. At Coloplast, a Danish medtech company, he led major initiatives, including an acquisition that eventually brought him to the U.S. from Denmark. Now at Neuspera, Steffen is steering an innovative approach to neuromodulation technology. Neuspera’s device is designed to treat conditions like overactive bladder, using a less invasive, “microimplant” system that doesn’t require a traditional battery or bulky hardware. Here's a quick look at Steffen’s interview with Scott Nelson: 🌐 In medtech, development timelines can stretch over a decade. Before pouring resources into an idea, it’s crucial to confirm its relevance and market potential and then get the right people on board. Building your network early helps with finding the right talent as well as the right investors. 🕰️ Align your pace with the development stage you’re at. Move fast in early development but slow down and be thorough in the clinical stages. Then, be ready to pick up speed and go full throttle when commercialization approaches. 🔋Perfect your pitch and refine your story to make a strong impression. View each investor interaction as a long-term relationship rather than a one-time opportunity; stay in touch, and show consistent progress. Above all, bring energy and resilience to each pitch. Click the link in the comments for the full interview. This Medsider episode was brought to you by FastWave Medical, a hot IVL startup in the cardiovascular space. Don’t miss out on their next fundraise (more details in the comments). P.S. - We recently launched Medsider Mentors Volume VI, which is packed with insights and learnings from founders and CEOs of some of the most dynamic medical device and health technology startups in the world. Click the link in the comment section for this latest edition now available exclusively to our premium members.

Transforming healthcare through innovation! The MedTech Innovator 2025 program is now accepting applications. This global initiative supports groundbreaking medical technology startups, offering mentorship, funding opportunities, and industry connections to accelerate your impact. Ready to revolutionize healthcare? Apply now: https://lnkd.in/dw7fNFvQ #MedTech #Innovation #HealthcareTechnology #StartupFunding #TechForGood #GlobalImpact #MedTechInnovator2025

Wednesday Spotlight: Highlighting Innovation in the #HealthTech Industry! This week's spotlight shines on the NYC-based startup, Medmo: Founded by Lucas Takahashi 🩻 and Christopher Kelly, MD, MS, FACC, Medmo is transforming the way medical imaging is scheduled and completed. They've created a platform that streamlines the entire process, from scheduling to completion, saving patients time and money. Why Medmo is making waves: ➡ Seamless Scheduling and Tracking: Medmo automates scheduling tasks, reducing the burden on patients and providers. ➡ Reduced Administrative Burden: By streamlining the imaging process, Medmo saves healthcare providers time and resources. ➡ Improved Patient Outcomes: Patients can receive their imaging results faster and more efficiently. ➡ Nationwide Reach: Medmo has partnered with leading healthcare organizations across the country, making their platform accessible to a wide range of patients. Medmo is tackling a major obstacle in the healthcare system: ensuring that patients can access high-quality medical imaging services without unnecessary delays or complications. #NYCStartups #Medicalimaging #Startups

🌟 Proud moment at the "ABCs of Medical Devices and IVD Commercialization Journey"! 🌟 It was an insightful day at the Research and Innovation Circle of Hyderabad's annual flagship program. Connecting with experts in the field, exploring the journey of MedTech startups, and diving deep into innovation and regulatory frameworks were truly inspiring. Special highlights: - Interactive sessions on regulatory insights - Patent discussions for AI/ML in healthcare - Showcasing innovative startup ideas! The journey of transforming innovative ideas into impactful healthcare solutions continues! 💼💡 #MedTech #Innovation #HealthcareRevolution #Startups #MedicalDevices #SmartMedTech #CommercializationJourney #InnovationJourney #HealthcareStartups #ProudMoment